Nova Patents
LTIP1976A

Compositions for inhalation, method for priparing the same, using the same and inhaler

Abstract

respiratory alleviation preparations. SUBSTANCE: composition in the form of dry powder contains pharmaceutically-active polypeptide associated with surfactant-type promoter. The latter increases absorption of polypeptide in lower respiratory pathways. Its amount represents more than 10% of the total weight of polypeptide and promoter. At least 50% of powder consists of particles with diameter lesser than or equal to 10 mcm, or agglomerates of these particles. Inhaled composition provides system transportation of therapeutically-active peptides and proteins into lungs and absorption of drugs. EFFECT: enhanced treatment efficiency. 31 cl, 3 dwg, 1 tbl, 4 ex

Term

Term ended

Projected expiry passed 24 June 2014, 12.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

132 members in 36 offices

This recordMember, by publication datePriority claim26 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
9302198SwedenA
93021988–––
SE19930002198–––

Members132

Family members, oldest first
DocumentOfficeKind
SE9302198D0SwedenD0
SE9400370D0SwedenD0
SE9400371D0SwedenD0
SE9400372D0SwedenD0
IL110084D0IsraelD0
IL110085D0IsraelD0
IS4178AIcelandA
IS4179AIcelandA
CA2166108A1CanadaA1
CA2166109A1CanadaA1
WO9500127A1World Intellectual Property Organization (WIPO)A1
WO9500128A1World Intellectual Property Organization (WIPO)A1
AU7090194AAustraliaA
AU7090294AAustraliaA
LTIP1977ALithuaniaA
MX9404761AMexicoA
MX9404762AMexicoA
ZA944378BSouth AfricaB
ZA944379BSouth AfricaB
LTIP1976AThis recordLithuaniaA
SE9400370LSwedenL
SE9400371LSwedenL
LT3445BLithuaniaB
NO955226D0NorwayD0
NO955227D0NorwayD0
FI956227AFinlandA
FI956228AFinlandA
LT3649BLithuaniaB
NO955226LNorwayL
NO955227LNorwayL
HU9503659D0HungaryD0
HU9503660D0HungaryD0
PL312205A1PolandA1
PL312210A1PolandA1
BR9406907ABrazilA
BR9406908ABrazilA
US5506203AUnited States of AmericaA
EP0706382A1European Patent Office (EPO)A1
EP0706383A1European Patent Office (EPO)A1
CZ339395A3CzechiaA3
CZ342895A3CzechiaA3
US5518998AUnited States of AmericaA
CN1127471AChinaA
CN1129904AChinaA
JPH08512027AJapanA
JPH09500621AJapanA
SK160195A3SlovakiaA3
SK160295A3SlovakiaA3
HUT75065AHungaryA
HUT75066AHungaryA
US5658878AUnited States of AmericaA
NZ268137ANew ZealandA
NZ268138ANew ZealandA
US5747445AUnited States of AmericaA
AU692780B2AustraliaB2
AU692781B2AustraliaB2
US5830853AUnited States of AmericaA
NZ328476ANew ZealandA
HK1009584A1Hong Kong, ChinaA1
HK1009587A1Hong Kong, ChinaA1
IL110084AIsraelA
EP0706382B1European Patent Office (EPO)B1
US5952008AUnited States of AmericaA
AT183920TAustriaT
ATE183920T1AustriaT1
EG20599AEgyptA
DE69420412D1GermanyD1
EE03221B1EstoniaB1
EE03222B1EstoniaB1
ES2138087T3SpainT3
DK0706382T3DenmarkT3
GR3031974T3GreeceT3
PL178261B1PolandB1
DE69420412T2GermanyT2
PL178403B1PolandB1
RU2148398C1Russian FederationC1
TW402506BTaiwan Province of ChinaB
CZ287314B6CzechiaB6
RU2159108C2Russian FederationC2
US6165976AUnited States of AmericaA
CZ287656B6CzechiaB6
US5506203C1United States of AmericaC1
US5518998C1United States of AmericaC1
NZ328475ANew ZealandA
MY112098AMalaysiaA
IS1768BIcelandB
IL110085AIsraelA
US2001003739A1United States of AmericaA1
EP0706383B1European Patent Office (EPO)B1
US2001025037A1United States of AmericaA1
AT206046TAustriaT
ATE206046T1AustriaT1
US6306440B1United States of AmericaB1
DE69428442D1GermanyD1
EG21484AEgyptA
DK0706383T3DenmarkT3
IS1796BIcelandB
ES2162865T3SpainT3
PT706383EPortugalE
DE69428442T2GermanyT2
Showing 100 of 132